FGF2-primed 3D spheroids producing IL-8 promote therapeutic angiogenesis in murine hindlimb ischemia

Abstract Peripheral artery disease is a progressive, devastating disease that leads to critical limb ischemia (CLI). Therapeutic angiogenesis using stem cell therapy has emerged as a promising approach for its treatment; however, adapting cell-based therapy has been limited by poor cell survival and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jungkyun Choi, Wooshik Choi, Yunji Joo, Haeun Chung, Dokyun Kim, Seung Ja Oh, Sang-Heon Kim
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Acceso en línea:https://doaj.org/article/9f82ccb5f8b1426583a1c44e3d70a113
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9f82ccb5f8b1426583a1c44e3d70a113
record_format dspace
spelling oai:doaj.org-article:9f82ccb5f8b1426583a1c44e3d70a1132021-12-02T15:10:56ZFGF2-primed 3D spheroids producing IL-8 promote therapeutic angiogenesis in murine hindlimb ischemia10.1038/s41536-021-00159-72057-3995https://doaj.org/article/9f82ccb5f8b1426583a1c44e3d70a1132021-08-01T00:00:00Zhttps://doi.org/10.1038/s41536-021-00159-7https://doaj.org/toc/2057-3995Abstract Peripheral artery disease is a progressive, devastating disease that leads to critical limb ischemia (CLI). Therapeutic angiogenesis using stem cell therapy has emerged as a promising approach for its treatment; however, adapting cell-based therapy has been limited by poor cell survival and low treatment efficiency. To overcome unmet clinical needs, we developed a fibroblast growth factor 2 (FGF2)-immobilized matrix that enabled control of cell adhesion to the surface and exerted a priming effect on the cell. Human adipose-derived stem cells (hASCs) grown in this matrix formed a functionally enhanced cells spheroid (FECS-Ad) that secreted various angiogenic factors including interleukin-8 (IL-8). We demonstrated that IL-8 was upregulated by the FGF2-mediated priming effect during FECS-Ad formation. Immobilized FGF2 substrate induced stronger IL-8 expression than soluble FGF2 ligands, presumably through the FGFR1/JNK/NF-κB signaling cascade. In IL-8-silenced FECS-Ad, vascular endothelial growth factor (VEGF) expression was decreased and angiogenic potential was reduced. Intramuscular injection of FECS-Ad promoted angiogenesis and muscle regeneration in mouse ischemic tissue, while IL-8 silencing in FECS-Ad inhibited these effects. Taken together, our data demonstrate that IL-8 contributes to therapeutic angiogenesis and suggest that FECS-Ad generated using the MBP-FGF2 matrix might provide a reliable platform for developing therapeutic agents to treat CLI.Jungkyun ChoiWooshik ChoiYunji JooHaeun ChungDokyun KimSeung Ja OhSang-Heon KimNature PortfolioarticleMedicineRENnpj Regenerative Medicine, Vol 6, Iss 1, Pp 1-15 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
spellingShingle Medicine
R
Jungkyun Choi
Wooshik Choi
Yunji Joo
Haeun Chung
Dokyun Kim
Seung Ja Oh
Sang-Heon Kim
FGF2-primed 3D spheroids producing IL-8 promote therapeutic angiogenesis in murine hindlimb ischemia
description Abstract Peripheral artery disease is a progressive, devastating disease that leads to critical limb ischemia (CLI). Therapeutic angiogenesis using stem cell therapy has emerged as a promising approach for its treatment; however, adapting cell-based therapy has been limited by poor cell survival and low treatment efficiency. To overcome unmet clinical needs, we developed a fibroblast growth factor 2 (FGF2)-immobilized matrix that enabled control of cell adhesion to the surface and exerted a priming effect on the cell. Human adipose-derived stem cells (hASCs) grown in this matrix formed a functionally enhanced cells spheroid (FECS-Ad) that secreted various angiogenic factors including interleukin-8 (IL-8). We demonstrated that IL-8 was upregulated by the FGF2-mediated priming effect during FECS-Ad formation. Immobilized FGF2 substrate induced stronger IL-8 expression than soluble FGF2 ligands, presumably through the FGFR1/JNK/NF-κB signaling cascade. In IL-8-silenced FECS-Ad, vascular endothelial growth factor (VEGF) expression was decreased and angiogenic potential was reduced. Intramuscular injection of FECS-Ad promoted angiogenesis and muscle regeneration in mouse ischemic tissue, while IL-8 silencing in FECS-Ad inhibited these effects. Taken together, our data demonstrate that IL-8 contributes to therapeutic angiogenesis and suggest that FECS-Ad generated using the MBP-FGF2 matrix might provide a reliable platform for developing therapeutic agents to treat CLI.
format article
author Jungkyun Choi
Wooshik Choi
Yunji Joo
Haeun Chung
Dokyun Kim
Seung Ja Oh
Sang-Heon Kim
author_facet Jungkyun Choi
Wooshik Choi
Yunji Joo
Haeun Chung
Dokyun Kim
Seung Ja Oh
Sang-Heon Kim
author_sort Jungkyun Choi
title FGF2-primed 3D spheroids producing IL-8 promote therapeutic angiogenesis in murine hindlimb ischemia
title_short FGF2-primed 3D spheroids producing IL-8 promote therapeutic angiogenesis in murine hindlimb ischemia
title_full FGF2-primed 3D spheroids producing IL-8 promote therapeutic angiogenesis in murine hindlimb ischemia
title_fullStr FGF2-primed 3D spheroids producing IL-8 promote therapeutic angiogenesis in murine hindlimb ischemia
title_full_unstemmed FGF2-primed 3D spheroids producing IL-8 promote therapeutic angiogenesis in murine hindlimb ischemia
title_sort fgf2-primed 3d spheroids producing il-8 promote therapeutic angiogenesis in murine hindlimb ischemia
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/9f82ccb5f8b1426583a1c44e3d70a113
work_keys_str_mv AT jungkyunchoi fgf2primed3dspheroidsproducingil8promotetherapeuticangiogenesisinmurinehindlimbischemia
AT wooshikchoi fgf2primed3dspheroidsproducingil8promotetherapeuticangiogenesisinmurinehindlimbischemia
AT yunjijoo fgf2primed3dspheroidsproducingil8promotetherapeuticangiogenesisinmurinehindlimbischemia
AT haeunchung fgf2primed3dspheroidsproducingil8promotetherapeuticangiogenesisinmurinehindlimbischemia
AT dokyunkim fgf2primed3dspheroidsproducingil8promotetherapeuticangiogenesisinmurinehindlimbischemia
AT seungjaoh fgf2primed3dspheroidsproducingil8promotetherapeuticangiogenesisinmurinehindlimbischemia
AT sangheonkim fgf2primed3dspheroidsproducingil8promotetherapeuticangiogenesisinmurinehindlimbischemia
_version_ 1718387648801800192